Conversion from failed antireflux surgery to RefluxStop: A multicenter feasibility, technical evaluation, safety, and effectiveness study with 30 consecutive cases - Summary - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Transitioning from Ineffective Antireflux Surgery to RefluxStop: A Multicenter Study Assessing Feasibility, Technical Aspects, Safety, and Efficacy in 30 Consecutive Cases
To report the feasibility and outcomes of converting to RefluxStop after failed antireflux surgery (ARS) and discuss surgical considerations of conversion.
Approach:
Key Findings:
Most subjects (53.3%) were female, with a median age of 55 years and median BMI of 26.9 kg/m2.
86.7% of patients had hiatal hernia (HH) at baseline, with 33.3% having HH ≥4 cm.
93.3% of subjects were on PPI therapy post-ARS, with 86.7% experiencing persistent symptoms before RefluxStop.
Interpretation:
RefluxStop may be a feasible option for patients with persistent GERD symptoms after failed ARS, showing potential for improved outcomes.
Limitations:
The study is limited by its retrospective design and small sample size.
Data was collected from two centers, which may affect generalizability.
Conclusion:
RefluxStop surgery may provide a suitable alternative for patients with failed ARS, offering a novel approach to managing GERD.
Vascular surgery continues to evolve as new endovascular technologies, hybrid procedures and emerging applications of artificial intelligence expand how physicians can approach complex vascular disease.
Operative-time–adjusted findings favored the ipsilateral technique, while absolute fluoroscopy time and radiation exposure remained similar between approaches.